Organization · Venture Capital
CARMA FUND Management GmbH
CARMA FUND Management GmbH operates CARMA FUND I, an early-stage venture fund focused on life science and healthcare technologies, based in Munich and Frankfurt am Main.
Overview
What CARMA FUND Management GmbH does
What CARMA FUND Management GmbH is
CARMA FUND Management GmbH operates CARMA FUND I, an early-stage venture fund focused on life science and healthcare technologies, based in Munich and Frankfurt am Main.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find CARMA FUND Management GmbH elsewhere
Open the official website or a supported primary organization account.
Capability profile
CARMA FUND Management GmbH as a funder
Investment thesis
CARMA FUND I invests in promising startups and high-potential academic projects in life science, primarily sourced from partner institutions. The fund focuses on new therapeutic and diagnostic approaches, platform technologies, medical devices, and digital health.
Focus narrative
The fund invests in early-stage companies and projects within the Life Science and medical sectors, welcoming applications for funding from all European sources. CARMA FUND I is particularly interested in startups that are developing innovative therapeutic and diagnostic solutions, as well as digital health technologies.
Value beyond capital
CARMA FUND I adds value to its portfolio companies by leveraging its strong network of academic and institutional partners, providing access to cutting-edge research and development resources. The fund also offers strategic guidance and support in navigating the complexities of the life sciences sector, helping startups accelerate their growth and achieve successful market entry.
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 16
Portfolio context
Notable portfolio companies include: Genome Biologics: Focuses on therapeutic target and drug discovery in cardiovascular and cardiometabolic diseases. Dimericon Therapeutics: A biotech company exploring crosslinked helix dimers as therapeutics for hard-to-drug intracellular protein-protein interactions. Epignostix: Specializes in molecular tumor classification using DNA methylation profiling and machine learning. KUPANDO: Develops TLR 4/7 agonists for immunotherapy in cancer and infectious diseases. InContAlert GmbH: A MedTech startup creating a wearable device to measure urinary bladder filling levels using AI algorithms. Aignostics: Focuses on computational pathology for pharmaceutical research and clinical trials. Symphera: Innovates laparoscopic surgery by eliminating manual instrument changes during operations. Thryve: Provides a wearable API for health data integration across various health services. CereGate: Develops a Computer-Brain Interface technology for treating neurological disorders. TECregen AG: A public company focused on developing and distributing pharmaceutical products. Akribion Therapeutics: Works on RNA-guided technology for programmable cell depletion targeting specific diseases. Allogenetics: Aims to create immunological invisibility for donor organs to prevent rejection. Salvina Therapeutics: Targets TNF superfamily members for innovative antibody therapies.
Common questions
What to know about CARMA FUND Management GmbH
Upseed classifies CARMA FUND Management GmbH under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.